PMDA drug package insert
リクシアナOD錠15mg
PMDA Prescription drug · 第一三共株式会社 · package insert Nov 26, 2025
Key facts
| Brand names | リクシアナOD錠15mg, リクシアナOD錠30mg, リクシアナOD錠60mg |
|---|---|
| Nonproprietary names | エドキサバントシル酸塩水和物 |
| Companies | 製造販売元／第一三共株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 経口FXa阻害剤 |
| Therapeutic category codes | 873339 |
| YJ codes | 3339002F4029, 3339002F5025, 3339002F6021 |
| Approval numbers | 22900AMX00946, 22900AMX00947, 22900AMX00948 |
| Package insert edition | 第8版 |
| Package insert date | Nov 26, 2025 |
| PMDA document key | 430574_3339002F4029_1 |
| PMDA company code | 430574 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: